01 1Kern Pharma, S. L.
01 1Remifentanil hydrochloride
01 1Spain
Registration Number : 226MF10170
Registrant's Address : Pol. Ind. Colo(´)n II Venus, 72 08228 Terrassa (Barcelona)-Spain
Initial Date of Registration : 2014-09-01
Latest Date of Registration : 2018-10-12
92
PharmaCompass offers a list of Remifentanil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Remifentanil manufacturer or Remifentanil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Remifentanil manufacturer or Remifentanil supplier.
PharmaCompass also assists you with knowing the Remifentanil API Price utilized in the formulation of products. Remifentanil API Price is not always fixed or binding as the Remifentanil Price is obtained through a variety of data sources. The Remifentanil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 132875-61-7 (Parent) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 132875-61-7 (Parent), including repackagers and relabelers. The FDA regulates 132875-61-7 (Parent) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 132875-61-7 (Parent) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 132875-61-7 (Parent) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 132875-61-7 (Parent) supplier is an individual or a company that provides 132875-61-7 (Parent) active pharmaceutical ingredient (API) or 132875-61-7 (Parent) finished formulations upon request. The 132875-61-7 (Parent) suppliers may include 132875-61-7 (Parent) API manufacturers, exporters, distributors and traders.
click here to find a list of 132875-61-7 (Parent) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 132875-61-7 (Parent) Drug Master File in Japan (132875-61-7 (Parent) JDMF) empowers 132875-61-7 (Parent) API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 132875-61-7 (Parent) JDMF during the approval evaluation for pharmaceutical products. At the time of 132875-61-7 (Parent) JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 132875-61-7 (Parent) suppliers with JDMF on PharmaCompass.
We have 1 companies offering 132875-61-7 (Parent)
Get in contact with the supplier of your choice:
